Valuation: Yuhan Corporation

Market Cap 5,325B 3.61B 3.17B 2.95B 2.71B 5.09B 350B 5.18B 35.27B 13.76B 170B 13.55B 13.26B 591B P/E 2026 *
39.2x
P/E 2027 * 25.6x
Enterprise Value 5.24B 3.55M 3.12M 2.9M 2.67M 5M 344M 5.09M 34.68M 13.53M 168M 13.33M 13.04M 582M EV / Sales 2026 *
2.24x
EV / Sales 2027 * 1.99x
Free-Float
64.28%
Yield 2026 *
0.78%
Yield 2027 * 0.79%
1 day+1.71%
1 week+2.73%
Current month+1.71%
1 month-2.72%
3 months-24.92%
6 months-31.87%
Current year-36.48%
1 week 67,900
Extreme 67900
71,900
1 month 65,000
Extreme 65000
74,550
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.7143
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
President 67 2024-03-14
Director of Finance/CFO 58 -
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 59 2021-03-18
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.71%+2.73%-42.88%+11.90% 3.54B
+2.36%+5.56%+59.88%+18.20% 315B
+1.72%-0.61%+27.81%-10.31% 67.93B
+3.88%+6.62%+40.49%+88.48% 9.23B
-1.26%-1.72%+4.64%-3.98% 8.43B
+3.78%+1.92%-21.25%-6.67% 4.07B
+0.07%-9.52%-5.52%+22.21% 3.77B
+0.53%-1.13%+44.44%+54.17% 2.72B
-0.30%-6.60%+4.82%-10.21% 2.13B
+0.61%-5.82%-17.93%+37.29% 1.95B
Average +1.32%+1.98%+9.45%+20.11% 41.86B
Weighted average by Cap. +2.15%+3.23%+50.15%+14.60%

Financials

2026 *2027 *
Net sales 2,333B 1.58B 1.39B 1.29B 1.19B 2.23B 153B 2.27B 15.45B 6.03B 74.7B 5.94B 5.81B 259B 2,586B 1.75B 1.54B 1.43B 1.32B 2.47B 170B 2.51B 17.13B 6.68B 82.8B 6.58B 6.44B 287B
Net income 143B 96.93M 85.25M 79.2M 72.84M 137M 9.39B 139M 947M 369M 4.58B 364M 356M 15.88B 212B 144M 127M 118M 108M 203M 13.94B 206M 1.41B 549M 6.8B 540M 529M 23.59B
Net Debt -88.37B -59.9M -52.69M -48.94M -45.02M -84.42M -5.8B -85.93M -585M -228M -2.83B -225M -220M -9.82B -166B -113M -99.13M -92.1M -84.7M -159M -10.92B -162M -1.1B -430M -5.32B -423M -414M -18.47B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-07-22 71,400.00 +1.71% 197,578
26-07-22 ₩70,200.00 +0.86% 255,879
26-07-21 ₩69,600.00 +0.58% 185,984
26-07-20 ₩69,200.00 -2.26% 178,034
26-07-16 ₩70,800.00 +1.87% 245,221
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
71,400.00KRW
Average target price
127,555.56KRW
Spread / Average Target
+78.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock